Emanuele Monti

Emanuele Monti is a prominent member of the Board of Directors of the Italian Medicines Agency (Agenzia Italiana del Farmaco), where he plays a crucial role in the approval and availability of orphan drugs for rare diseases. Recently, he highlighted the advancements in treatment options for previously incurable rare diseases, emphasizing the importance of continued research and development in this vital area of healthcare.